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Abstract
Background: The current chemical space of known small molecules is estimated to exceed 10
60 structures.
Though the largest physical compound repositories contain only a few tens of millions of unique compounds,
virtual screening of databases of this size is still difficult. In recent years, the application of physicochemical
descriptor-based profiling, such as Lipinski’s rule-of-five for drug-likeness and Oprea’s criteria of lead-likeness, as
early stage filters in drug discovery has gained widespread acceptance. In the current study, we outline a kinase-
likeness scoring function based on known kinase inhibitors.
Results: The method employs a collection of 22,615 known kinase inhibitors from the ChEMBL database. A kinase-
likeness score is computed using statistical analysis of nine key physicochemical descriptors for these inhibitors.
Based on this score, the kinase-likeness of four publicly and commercially available databases, i.e., National Cancer
Institute database (NCI), the Natural Products database (NPD), the National Institute of Health’s Molecular Libraries
Small Molecule Repository (MLSMR), and the World Drug Index (WDI) database, is analyzed. Three of these
databases, i.e., NCI, NPD, and MLSMR are frequently used in the virtual screening of kinase inhibitors, while the
fourth WDI database is for comparison since it covers a wide range of known chemical space. Based on the kinase-
likeness score, a kinase-focused library is also developed and tested against three different kinase targets selected
from three different branches of the human kinome tree.
Conclusions: Our proposed methodology is one of the first that explores how the narrow chemical space of
kinase inhibitors and its relevant physicochemical information can be utilized to build kinase-focused libraries and
prioritize pre-existing compound databases for screening. We have shown that focused libraries generated by
filtering compounds using the kinase-likeness score have, on average, better docking scores than an equivalent
number of randomly selected compounds. Beyond library design, our findings also impact the broader efforts to
identify kinase inhibitors by screening pre-existing compound libraries. Currently, the NCI library is the most
commonly used database for screening kinase inhibitors. Our research suggests that other libraries, such as MLSMR,
are more kinase-like and should be given priority in kinase screenings.
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Chemical space can be defined as “the total descriptor
s p a c ec o v e r e db ya l lt h ek n o w na n dp o s s i b l es m a l l
organic compounds” [1]. Chemical space is thus so vast
that it prompted Lipinsky and Hopkins to compare it to
the total number of stars in the cosmos [2]. Estimates of
the total number of possible small molecules vary from
10
8 to 10
200 depending upon the criteria used. For
example, Bohacek et al. [3] estimated it to be 10
60,
when based on a maximum number of 30 C, N, O, and
S atoms; Ertl [4] estimated a total of 10
20-10
24 possible
small molecules, based on current synthetic methods;
and Ogata et al. [5] estimated a range of 10
8-10
19 possi-
ble small molecules, based on combinations of known
Protein Data Bank (PDB) ligands.
The CAS registry [6] is the largest collection of dis-
closed chemical substance information and currently
contains more than 55 million organic and inorganic
compounds. Other notable collections of compounds
include the Chemical Structure Lookup Service (CSLS)
[7], with around 46 million unique compounds, Pub-
Chem [8] and Chemspider [9], with around 20 million
compounds each, and ZINC [10] with around 13 million
compounds, along with hundreds of other public or pri-
vate collections ranging from a few thousands to a few
millions of compounds. Even though such vast collec-
tions only constitute a small fraction of possible chemi-
cal space, it is still very difficult to apply a typical
biological screen to all molecules in a collection when
seeking novel hits on targets of interest [11]. Along with
database size, another concern is that very few com-
pounds in these databases are biologically relevant; in
other words, the sub-regions of chemical space that are
relevant to biology is small [1,12]. Since not every region
of chemical space defined by a compound database is
biologically relevant, screening the entire database for a
particular target is a waste of resources. In recent years,
the focus has shifted away from screening large com-
pound libraries to screening smaller, more target-
focused libraries that are generated using all relevant
information about the target and its known active com-
pounds [13-17].
The design of focused libraries using physicochemical-
based descriptors is known as chemography. The under-
lying principle of this technique is that structurally simi-
lar compounds are likely to have similar interactions
with associated targets, along with having similar physi-
cochemical property ranges [18-22]. Such profiling of
compounds based on physicochemical descriptors has
been in use since the late 1990’s and many excellent
research articles on this concept exist [23-34]. The most
popular methods are the rules defining drug-likeness
proposed by Lipinski et al. [35] and more recently by
Veber et al. [31] and Oprea et al. [11,29,36,37]. These
rules are based on simple physicochemical descriptors
such as molecular weight, number of hydrogen bond
donors and acceptors, logP, polar surface area, and
number of rotatable bonds. Since their publication,
these rules have been extensively used to differentiate
between drugs, lead-like compounds, and other com-
pounds, and have also been used as filters to reduce the
size of screening databases. Ideally, these rules must be
based on individual target-based known small molecule
exemplars. Previously such rules have been applied in a
few target classes like G protein-coupled receptors
(GPCRs) and kinases [38,39]. The ultimate goal of such
applications is to maximize the diversity of hits while
minimizing the size of screening libraries to cover only
the biologically relevant space for a particular drug
target.
Our focus in this work is to apply physicochemical
descriptor-based filters to make kinase-likeness rules.
Previously, to make a kinase-focused library, two main
types of approaches have been used: 1) scaffold-based
design, [40-45] or 2) 2D and 3D (pharmacophore) simi-
larity-based design [46-48]. Both approaches utilize
information from known kinase active and inactive com-
pounds. While these approaches have been successfully
used in test cases, their utility in finding novel active
compounds is limited due to fact that the new com-
pounds selected are often structurally similar to the
compounds that are initially used as templates. In com-
parison, our method, which is based on physicochemical
descriptors of known active compounds, has the advan-
tage of being able to select novel structural scaffolds
since the physicochemical properties are not directly
tied to any specific chemical scaffold. The method is
also easy to implement and can handle very large com-
pound data sets.
Protein kinases, which are important signaling
enzymes that catalyze a phosphoryl transfer from ATP
to a given protein or peptide substrate, are the second
most popular drug targets after GPCRs and account for
roughly one third of all drug discovery projects [49].
T h e r ea r ec u r r e n t l ym o r et h a n5 1 8d i s t i n c th u m a np r o -
tein kinase genes spread across seven kinase families
[50]. Each kinase contains a conserved catalytic domain
consisting of N-terminal and C-terminal lobes con-
nected by a hinge region [51]. The ATP-binding site is
located in a deep cleft between these lobes. Numerous
structural studies of kinases have shown that, although
there is substantial diversity in sequences, the structure
of the ATP-binding site [52] is relatively conserved.
Over the years, thousands of inhibitors (actives) have
been identified for a variety of kinases. Most of these
actives compete with ATP for the ATP-binding site and
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the binding site architecture among kinases suggests
that kinase actives occupy a common, biologically rele-
vant region of chemical space that is compatible with
the structural and chemical constraints of the ATP-
binding site topology. This region can be roughly
described by the common steric and electronic features,
i.e., physicochemical properties, among known ATP-
mimetic kinase actives [39,52]. A rigorous, high-
throughput, statistical approach for identifying these fea-
tures presents the opportunity to design kinase-focused
libraries which consist of compounds that contain com-
plementary features to the common ATP-mimetic
actives.
To this end, we collected a set of 22,615 known kinase
actives from the ChEMBL database [53]. This database
was assembled from more than 1,200 published research
articles. We then tested a range of physicochemical
descriptors and identified those that significantly distin-
guish between kinase and non-kinase active compounds.
The measured distributions of these properties from
kinase actives was then used to train a kinase-likeness
scoring function. We used this scoring function to rank
order the following small molecule databases for their
kinase-likeness: The National Cancer Institute database
(NCI), [54] the Natural Products database (NPD), [10]
and the National Institute of Health’sM o l e c u l a r
Libraries Small Molecule Repository (MLSMR), [55] all
of which are commonly used in screening for novel
kinase actives. We further validated our results by rank
ordering the same databases using another correlation
matrix-based scoring function originally developed by
Ohno et al. [56].
Finally, we used the kinase-likeness scoring function
to generate a kinase-focused library. In order to demon-
strate the utility of this approach, we employed a dock-
ing-based screen of this focused library against three
diverse and well-known kinase targets to see if the
screening results are enriched for tighter binding com-
pounds relative to standard screening libraries. We
found that the top compounds from the kinase-focused
library indeed made better contacts with the kinase
binding pockets than the top compounds from standard
screening libraries.
Results show that our kinase scoring function, based
on physicochemical descriptors, successfully generates
kinase-focused libraries. As a result, application of this
scoring function can be a useful first step in kinase
actives lead discovery workflows.
Materials and methods
Database Collection
Experimentally validated kinase actives were compiled
from the ChEMBL compound database, hereafter
referred to as the kinase binding database (KBD). A
compound was defined as a kinase active only if its Ki
or IC50 value was less than 10 μM. To test kinase-like-
ness of the compounds that are frequently used in vir-
tual screening of kinase inhibitors, the following publicly
available small-molecule databases were also collected:
the National Cancer Institute database (NCI), the Nat-
ural Products database (NPD), the National Institute of
Health’s Molecular Libraries Small Molecule Repository
(MLSMR). Additionally, for comparison, compounds
from the World Drug Index (WDI) database were also
collected since they cover a wide range of known chemi-
cal space. Both the NCI and the NPD databases were
downloaded from the ZINC UCSF collection [57] of
compounds, while the MLSMR compounds were down-
loaded from the PubChem database, [58] and the WDI
was obtained from Thomson Reuters [59]. The data pre-
processing and descriptor calculations were done with
Chemical Computing Group’s Molecular Operating
Environment (MOE), v. 2010.10, [60] and implemented
through Accelrys Pipeline Pilot, v. 8.0. [61]. The prepro-
cessing steps included removing counterions and solvent
molecules, setting protonation states and removing
metal-based structures. Molecules not in the weight
range of 100-700 daltons were also removed from the
databases. The final prepared databases numbered
22,615 (KBD), 264,554 (NCI), 103,668 (NPD), 343,605
(MLSMR), and 61,368 (WDI) compounds.
Properties previously used by Oprea et al. [29] in for-
mulating lead-likeness were used as the starting point.
These properties included molecular weight (Wt), octa-
nol/water partition coefficient (SlogP), topological polar
surface area (TPSA), and number of rotatable bonds
(RB) (bonds were considered rotatable if they a) had a
bond order of 1, b) were not a ring and c) had at least
two heavy neighbors). Additionally, the number of rings
(Rings), hydrogen bond acceptors (HBA), hydrogen
bond donors (HBD), number of nitrogen atoms (nN),
and number of oxygen atoms (nO) were also included.
Kinase-likeness Scoring Functions
For each KBD physicochemical property, there is a trend
towards a normal distribution (details in Results sec-
tion). Therefore, we utilized a multi-parameter Gaussian
scoring function, called the Kinase-Like Score (KLS), for
“kinase-likeness”. This function is given by:
KLS =
9
i=1e −

(Xi − μi)2
σ2
i

(1)
The values Xi ,w i t hi = 1 to 9, represent the physico-
chemical properties of Wt, RB, HBA, HBD, SlogP,
T P S A ,R i n g s ,n N ,a n dn O ,r e s p e c t i v e l y .T h ep a r a m e t e r s
μi and si represent the average and standard deviation
Singh et al. Journal of Cheminformatics 2012, 4:4
http://www.jcheminf.com/content/4/1/4
Page 3 of 12of each physicochemical property, Xi. The averages and
standard deviations were calculated using property dis-
tributions obtained from the KBD. In addition, for any
compound that fell outside the P10-P90 range (the
descriptor range that covers 80% of the compounds) in
any of its descriptors, a value of zero was assigned for
that descriptor’s contribution to the overall score. The
KLS s c o r er a n g e sf r o m0t o9 ,a n dc o m p o u n d sw i t h
scores toward the upper end of this range are more
kinase-like than compounds with scores toward the
lower end of this range. This scoring scheme shares
similarities to that published by Wager et al. [62]. In
their work, multi-parameter scoring functions were
derived for central nervous system compounds using the
properties ClogP, ClogD, Wt, TPSA, HBD, and pKa.
More elaborate schemes are found in papers such as
that by Oashi et al. [63] that describe a multivariate
Gaussian probability distribution to ascertain bioavail-
ability and drug likeness of small molecule compounds.
We calculated the KLS for all of the compounds in the
NCI, NPD, MLSMR, and WDI databases. High KLS
values of compounds in these libraries indicate that
these libraries are enriched with compounds having
similar physicochemical properties as those of known
kinase actives and ultimately may yield a higher enrich-
ment of kinase actives in screening.
Correlation Coefficient-based Scoring
In addition to the KLS, we applied another orthogonal
statistical approach based on a correlation coefficient-
based methodology to rank various databases for kinase-
likeness. A similar approach has already been applied by
Ohno et al. to rank order various test databases for
drug-likeness [56]. In this methodology we first com-
puted the correlation coefficient between every pair of
descriptors in our descriptor set using Pipeline Pilot
software. This was done for the NPD, NCI, MLSMR,
WDI, and KBD databases. Nine descriptor values were
considered, therefore a total of 36 correlation coefficient
values were determined for each database. In theory, if
the correlation matrices of two compound libraries are
similar, compounds in each library would be similar too.
Therefore, a compound library with a correlation matrix
similar to the KBD should include kinase-like molecules.
In this study, a scoring function of kinase-likeness
based on a comparison of correlation matrices (KLSC)
was defined as follows [56]:
KLSC =

i =j

|Ci,j(testdatabase) − Ci,j(kinasedatabase)|
36

(2)
In this equation, Ci, j (test database) and Ci, j (kinase
database) represent the correlation coefficient values
between two descriptors i and j in the test database and
kinase database, respectively. Finally, we calculated a
KLSC value for each of the databases, NPD, NCI, and
MLSMR with respect to the KBD.
Receiver Operating Characteristic (ROC) Plots
To determine the kinase-likeness of any given database
(test database) of compounds, we randomly chose 1% of
the known kinase compounds from the KBD and seeded
them into the NCI, NPD, MLMSR, and WDI databases.
The KLS was computed for each compound in the
seeded databases. The compounds were then sorted in
decreasing order by their KLS value, and a ROC plot
was constructed based on this ordering. The step of
mixing a random selection of kinase actives from the
KBD was repeated 10 times, and the average, maximum,
and minimum ROC curves and area under the curve
(AUC) were computed. For validation, a random 1% of
kinase actives were also extracted from the KBD and
mixed back with the KBD database to make ROC plots.
This strategy should result in a ROC curve correspond-
ing to a random selection of compounds from the data-
base. To determine if a different percentage of seeded
kinase compounds from the KBD gives different results,
we tried other percentages as well (2%, 5%, 10%, 50%,
and 100%). We found that the AUC value remains more
or less independent of percentage of seeded kinase
actives. As a result, only a selection of 1% was used.
Focused Library Construction, Target Selection, and Glide
Docking
We applied the KLS (Equation 1) to make a target-
focused library for kinases. For this, we initially pooled
the major databases (NCI, NPD, and MLSMR) together.
From this pool of 711,827 compounds, all the known
kinase actives and duplicates were removed and a
kinase-focused library was constructed by selecting the
top 10,000 compounds based on their kinase-likeness
score (KLS). This set is called the focused set. Another
test set of 10,000 randomly selected compounds was
also selected and called the random set. To test enrich-
ment, docking-based virtual screening (VS) was per-
formed against three kinase targets.
For docking calculations, the receptor and ligand
structures were prepared using the Protein Preparation
Workflow implemented in the Maestro graphical user
interface of the Schrodinger program suite. The various
steps involved in this process included removing water
molecules, protonating receptor and ligand, assigning
optimal tautomeric states of histidine residues, flipping
side chains of glutamine and asparagine residues if
required, optimizing hydrogen bonds, and energy mini-
mization. The native ligands, along with compounds
from the focused set and random set, were processed
using LigPrep [64] with Epik [65] to expand the proto-
nation and tautomeric states in the range of 7.0 ± 2.0
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done using GLIDE in standard precision (SP) mode [66]
for flexible docking. The binding affinities were esti-
mated as a Docking score (Glide score + Epik state
penalties). The docking protocol was validated by re-
docking the native ligands, each of which reproduced
the binding mode observed in the respective crystal
structures. Both the focused-set and random-set com-
pounds were docked, and the top hits were selected
using a docking score cutoff value equal to the docking
score of the native ligand in each crystal structure. The
number of kinase ligands with respect to the total num-
ber of ligands in the resulting hit list is an indication of
library enrichment.
Additionally, to show that the compounds in the
focused library constructed using the physicochemical
property based filtering are more diverse than scaffold-
based or similarity-based focused libraries, we conducted
a test. We first selected the Aldrich Market Select
(CNC-AMS) library available through ChemNavigator’s
iResearch library [67]. This library contains ~ 7 million
commercial compounds, all of which are readily purcha-
sable. To test for diversity of focused libraries, we used
an example of an already approved kinase drug Suniti-
nib. Sunitinib is a small-molecule targeting receptor tyr-
osine kinase and is approved by the FDA for the
treatment of both renal cell carcinoma and the imati-
nib-resistant gastrointestinal stromal tumor [68]. Using
Sunitinib’s chemical structure, we created three types of
focused libraries. First, we created a scaffold-based
library by collecting all the compounds from CNC-AMS
that contain the same cyclic scaffold as Sunitinib. Sec-
ond, we created a similarity-based library by collecting
the top 100 most similar compounds to drug Sunitinib
from CNC-AMS based on Tanimoto similarity score.
Third, we created a physiochemical property -based
focused library by applying our KLS score and selecting
the top 100 KLS scoring compounds from the CNC-
AMS library. To evaluate the diversity of each library,
we calculated the average of distance, where distance is
defined as ‘1 - similarity’, for every pair of collected
compounds in all the three libraries. Extended-connec-
tivity fingerprints_6 (ECFP_6) were used to calculate the
similarity [69]. For comparison, we also calculated the
average distance of sets of 100 randomly selected mole-
cules from the CNC-AMS database.
Results
Molecular Descriptors
Studies based on Lipinski’s rule-of-five [35] and Oprea’s
lead-like criteria [11] have established that specific sets
of properties, such as size, solubility, flexibility, polarity,
and hydrogen bond capacities, are sufficient to capture
significant molecular features and, in turn, the biological
properties of small molecules. In this study, we used
nine physicochemical descriptors that influence the
above-described properties to effectively quantify the
kinase-likeness of a given small molecule. Out of these
nine descriptors, six (Wt, RB, HBA, HBD, TPSA, and
SlogP) were used by Oprea [11]. In the case of kinase
targets, we have prior knowledge of binding site archi-
tecture, so three additional descriptors (Rings, nN and
nO) were added. These were included because planar
ring scaffolds are known to fit well in the ATP binding
pocket, and nitrogen and oxygen atoms play a large role
in making hydrogen bond contacts.
We compared the distribution of these descriptors for
kinase actives (KBD database) with those of molecules
f r o mt h eN P D ,N C I ,M L S M R ,a n dW D Id a t a b a s e s .
Comparison was done using a two-sided Student’s t test
[70] to determine if the difference in descriptor distribu-
tions between two databases was significant. The analy-
sis showed that, with the exception of the number of RB
between the KBD and MLSMR databases (a p value of
0.528), all other descriptors were significantly different
(p < 0.05). Hence, these nine different descriptors are
suitable for formulating a scoring function that can dif-
ferentiate between small molecules that are likely to
bind kinases (actives that have kinase-likeness) and
those that are not. The distribution plots of the nine
descriptors, along with the outliers, average values, stan-
dard deviation (SD) is shown in Figure 1 and Table 1. A
complete table with included P10-P90 (range covering
80% of the compounds) values is provided in the Addi-
tional File 1.
The statistical analysis of all descriptors shows that,
with the exception of nO, the average values of all the
o t h e rd e s c r i p t o r s ,i . e . ,( W t ,R B ,H B A ,H B D ,T P S A ,
SlogP, Rings, and nN) were higher for kinase active
compounds than for the compounds contained in the
WDI, NPD, NCI, and MLSMR databases. Of note, the
average RB value of the MLSMR compounds and aver-
age TPSA value of the WDI compounds were similar to
that of the kinase active compounds. Kinase actives had
t h el o w e s ta v e r a g ev a l u ef o rn Ow h i l ec o m p o u n d sf r o m
the WDI database had the highest nO value. This analy-
sis showed that, on average, the kinase active com-
pounds were heavier (more weight), more flexible (more
RB), more polar (more nN, HBA, and HBD) and more
hydrophobic (more SlogP and rings) than the com-
pounds in the other databases.
Kinase-likeness
We utilized the distinctive properties of kinase active com-
pounds to develop a kinase-likeness scoring function.
Based on the distribution of the descriptor values of kinase
actives from the KBD, we calculated a kinase-likeness
score, KLS, for each small molecule in the KBD, WDI,
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Page 5 of 12Figure 1 Distribution maps of nine calculated physicochemical descriptors for five databases: WDI (grey), NPD (orange), NCI (teal),
MLSMR (green), and KBD (blue). Each box plot shows a wide rectangular block of interquartile range (IQR) between the 1
st quartile and 3
rd
quartile (covering 50% of the total range). A long, narrow, solid rectangle is also shown within the IQR, indicating upper and lower adjacent
values (UAV and LAV). The dots beyond UAV and LAV are outliers.
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score reflects how similar each compound is with respect
to the physicochemical properties of known kinase actives.
To calculate how kinase-like these databases were, we gen-
erated an ROC plot (as described in the Methods section)
based on the sorted KLS.T h i si ss h o w ni nF i g u r e2 .I fa
small random set of kinase actives is seeded into the KBD,
and VS is performed using the KLS to calculate an ROC
AUC, this should produce an AUC value near 0.5. Our
results showed this to be 0.506 (upper left plot in Figure
2). This means that the KLS is unable to distinguish the
1% mixed kinase active compounds from other kinase
actives in the KBD; in other words, the compounds in the
KBD are kinase-like. This is an obvious result but provides
a good way to test if databases other than the KBD contain
a large number of kinase-like compounds. If similar
screening experiments with databases other than the KBD
result in computed AUC values near 0.5, these databases
would be deemed kinase-like. This in turn, indicates that
these databases are composed of compounds that primar-
ily have physicochemical properties similar to that of
kinase active compounds. Using these ROC plots and
associated AUC values, we can determine which databases
are kinase-like. Here we focused only on the NCI, NPD,
and MLSMR databases because of their common usage in
screening for kinase targets (Figure 2). The WDI database
was used as a comparison based on the diversity of com-
pounds within it.
Table 2 shows the p values computed using a two-
sided Student’s t test for comparison of AUC values
between the KBD and the other databases (WDI, NPD,
NCI, and MLSMR). Note that all p values were < 0.05,
indicating that the AUC distributions for the NCI, WDI,
NPD, and MLMSR databases were significantly different
than the AUC distribution for the KBD.
From our ROC analysis, based on AUC values, we
divided these databases into high, medium, and low
kinase-like categories. High kinase-likeness databases have
AUC values near 0.5. This is the case for the MLSMR
database with an AUC value of 0.57. Low kinase-likeness
databases have AUC values closer to 1.0. This is the case
for the NCI (AUC = 0.82) and the WDI (AUC = 0.81)
databases. Medium kinase-likeness databases have AUC
values near 0.75. This is the case for the NPD database
(AUC = 0.70). The high AUC result for WDI is expected
since it contains marketed and in-development small
molecule drugs that bind to a wide variety of protein tar-
gets. We believe that the lower AUC value for the
MLSMR and the comparatively higher AUC value for the
NCI database is a consequence of the more recent assem-
bly of the MLSMR database compared to the NCI data-
base. The MLSMR initiative started in 2005, whereas the
NCI has been operational since the late 1950’s. Research
on kinase inhibitors has only ramped up in recent decades
and consequently MLSMR, being the newer of the two
databases, contains more kinase active compounds than
the NCI. The NPD sits right in the middle with an AUC
of 0.7. The hypothesis is that although NPD represents a
hugely diverse set of natural product compounds (due to
the large size range of the compounds), some portions of
Table 1 Statistical parameters based on the distribution maps of nine calculated physicochemical descriptors for five
databases (DB): WDI, NPD, NCI, MLSMR, and KBD.
DB Total Outliers Avg SD Outliers Avg SD Outliers Avg SD
Weight HBA Rings
WDI 61368 1145 379 138 2469 3.6 2.7 656 3.1 1.7
NPD 103668 198 375 86 1264 3.2 1.6 0 3.6 1.3
NCI 264554 38 305 91 2161 2.8 1.9 34368 2.5 1.4
MLSMR 343605 2544 362 78 1843 3.4 1.5 131 3.0 1.0
KBD 22615 250 411 96 140 3.7 1.6 32 4.0 1.2
TPSA HBD nN
WDI 61368 2305 89 54 2511 1.7 1.8 747 1.9 1.9
NPD 103668 1299 78 34 683 1.1 1.1 1020 2.1 1.6
NCI 264554 5190 72 42 2751 1.1 1.3 4987 2.0 1.8
MLSMR 343605 4450 77 28 330 1.0 0.9 1292 2.9 1.4
KBD 22615 688 89 33 64 1.9 1.3 221 4.3 1.8
SlogP RB nO
WDI 61368 1940 2.2 2.7 2244 5.9 4.3 1488 4.2 3.2
NPD 103668 1387 2.6 2.0 836 5.3 3.0 603 3.8 1.9
NCI 264554 4903 2.0 2.3 6340 4.6 3.2 4908 3.0 2.1
MLSMR 343605 6776 2.8 1.4 1100 6.1 2.6 2438 3.0 1.7
KBD 22615 487 3.4 1.8 465 6.1 3.3 683 2.4 1.9
Also included is the number of compounds (Total), outliers, average (Avg), and standard deviation (SD).
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the NPD AUC value is not quite as high as the AUC
values of the WDI or MLSMR databases (because of the
kinase-like portions), but it is not as low as the KBD either
(because of the diversity).
Using in silico rules prior to screening can help focus
efforts on databases appropriate to protein targets of
interest. The results presented here suggest that, when
screening for potential kinase actives, it would be most
efficient to probe the databases in the following order:
MLSMR > NPD > WDI ≈ NCI.
To support our AUC-based results for the ranking of VS
databases, we further analyzed them using the KLSC score
(Equation 2), which is based on the similarity between the
correlation matrix of a test database and the KBD. The
calculated correlation matrix of nine physicochemical
descriptors is shown in Table 3 for KBD compounds.
The correlation matrices of the other databases (WDI,
NPD, NCI, and MLSMR) are provided in the Additional
File 2. Ohno et al. has recently applied a similar scoring
function, called the Drug Like Score (DLS), to compare
commercially available compound libraries, clinical can-
didate libraries, and several other chemical libraries with
a launched drug library to calculate drug likeness based
on six physicochemical descriptors [56].
Figure 2 ROC plots of five databases: KBD, WDI, NCI, NPD, and MLSMR. The Y-axis indicates the fraction of true positives (FTP) and the X-
axis indicates the fraction of true negatives (FTN). The table in the lower right shows the calculated maximum (upper light green line), mean
(dark green line) and minimum (lower light green line) AUC values of the ROC plots based on the 10 different calculations for each database.
AUC values closer to random (0.50) signify more kinase-likeness, meaning that kinase-likeness score is unable to distinguish the 1% of kinase
active compounds that were mixed in from the other compounds in a given database. This indicates that those compounds have
physicochemical properties that are similar to kinase active compounds. A diagonal reference line (area under the curve = 0.50) defines points
where kinases are not discernible from the test database compounds. As validation, randomly selected kinase compounds were mixed in with
the KBD (upper left plot) and an average AUC of 0.5 was observed.
Table 2 The p values computed from a two-sided
Student’s t test for comparison of AUC distributions
between the KBD, and WDI, NCI, NPD, and MLSMR
databases.
WDI NCI NPD MLSMR
AUC 0.807 0.818 0.702 0.568
p value 4.9E-05 4.3E-05 2.7E-04 2.6E-02
There is a statistically significant difference between the KBD AUC distribution
and the AUC distributions of WDI, NCI, NPD, and MLSMR respectively because
the p values for the comparisons are all < 0.05.
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and MLSMR databases are 0.114, 0.161, 0.079, and 0.066,
respectively. A lower KLSC value signifies higher kinase-
likeness for a database. The KLSC values shown above
reiterate what we found before, i.e., MLSMR contain the
most kinase-like active compounds of all the databases
studied. Overall, the ranking of kinase-likeness based on
KLSC values is MLSMR > NPD > WDI ≈ NCI. This is
similar to that observed in ROC-based AUC analysis
d e s c r i b e di nt h ep r e v i o u ss e c t i o na n ds h o w ni nT a b l e2 .
An additional statistical test based on Kolmogorov-Smir-
nov methodology (KS test) [71] is shown in Additional
File 3 along with the distribution of KLS values for all the
studied databases. The k value obtained by KS test further
confirmed the ranking of databases obtained by both the
AUC based ranking and the KLSC value based ranking.
Application in Docking-based Virtual Screening
With the aim of demonstrating the practicalities of the
kinase-likeness scoring function, two datasets were cre-
ated: a kinase-focused set and a random set. Both these
datasets contain 10,000 small molecules (details in
Methods section). To test which of these two datasets
was more enriched in kinase-binding compounds, we
performed VS of each against three different kinase tar-
gets selected from three different branches (families) of
the human kinome tree. The criteria for selecting these
kinase drug targets was that, 1) they should have been
used in previous structure-based VS studies, 2) they
should have been crystallized with reasonable resolution
(≤ 3.0Å) with bound ligand, and 3) each should be from
a different kinase family. With these criteria, we selected
B-Raf to represent the tyrosine kinase-like (TKL) family,
mitogen-activated protein kinase-activated protein
kinase 2 (MK2) to represent the Ca
2+/calmodulin-
dependent protein kinases (CaMK) family, and cyclin-
dependent kinase 2 (CDK2) to represent the CMGC
kinase family. The PDB codes for these proteins are
2FB8[72], 2PZY[73], and 1OIT[74] respectively.
A docking-based VS, as explained in the Methods sec-
tion, was performed using both the kinase-focused
compound set and the random compound set. The out-
comes were analyzed in terms of number of “hit” com-
pounds, defined as compounds that scored better than
the docked native ligand in each respective crystal struc-
ture of the selected targets. The results are shown in
Figure 3. In each case, three to four times more hits
were obtained from the focused compound set than
from the random compound set. Of note, many of the
top hit compounds from the focused set yielded a much
better docking score than the top hits from the random
set. These results demonstrate that the compounds from
VS of the focused set are not only more enriched for
kinase-like compounds than the random screen, but also
interact better with the kinase binding pockets.
To show that physicochemical property-based focused
libraries are more diverse than structure-based focused
libraries, we created three focused libraries based on the
kinase drug Sunitinib: scaffold-based, similarity-based,
and physicochemical properties-based. All three focused
Figure 3 Top virtual screening hits from the focused set
database (blue squares) and the random set database (red
triangles) for three selected kinase targets: a) B-Raf; b) MK2;
and c) CDK2. For each target, only those selected docking hits are
shown that yielded a better docking score than the native ligand
docking score for both screening libraries, i.e., the focused set and
the random set. A significant difference was observed in the
number of selected hits between these library sets, with better
enrichment of the focused set of compounds.
Table 3 Correlation matrix between nine physicochemical
descriptors for the KBD.
Property RB HBA HBD SlogP TPSA Rings nN nO
Weight 0.70 0.44 0.14 0.20 0.50 0.54 0.40 0.40
RB 0.39 0.13 0.01 0.52 0.00 0.29 0.43
HBA 0.45 -0.12 0.62 0.22 0.37 0.50
HBD -0.11 0.51 0.08 0.21 0.23
SlogP -0.44 0.29 -0.13 -0.26
TPSA 0.05 0.38 0.66
Rings 0.37 -0.04
nN -0.29
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Page 9 of 12libraries were extracted from the CNC-AMS database of
~ 7 million purchasable compounds. In the first case,
only the cyclic scaffold of drug Sunitinib was taken into
account when performing scaffold screening of CNC-
AMS. A total of 44 compounds were found to contain
similar cyclic scaffold. In the second case, the full struc-
ture of Sunitinib was used for screening and the top 100
similar compounds, based on Tanimoto similarity value,
were selected. In the third case, the KLS scoring func-
tion was applied on all the compounds of CNC-AMS
and top 100 scoring compounds were selected. The
average distance (1-similarity) between each pair of
molecules was 0.69, 0.74, and 0.85, for scaffold-base,
similarity-based, and the physicochemical property-
based (KLS score) focused libraries, respectively. For
comparison a collection of 100 randomly select com-
pounds from CNC-AMS shows average distance of 0.88.
This proves that the physicochemical property-based
focused library is more diverse than structure-based
focused libraries. In fact, the average distance value of
0.85 for the physicochemical property-based focused
library generated from CNC-AMS is as diverse as a col-
lection of random selected compounds from CNC-AMS.
Conclusion
Kinases represent one of the most important and thera-
peutically relevant drug target families involved in dis-
eases like cancer and various other neurodegenerative,
infectious and inflammatory diseases. In the past few
years, various computational methodologies have been
employed to facilitate the kinase drug discovery effort
through the screening of small compound databases.
Many of these methodologies focus on steps that reduce
the size of screening databases. For example, the most
common types of pre-screening filters are based on
selective and preferential kinase scaffold-based filtering
and 2D- and 3D-based similarity filtering using the tem-
plates of known kinase active compounds. In the work
presented here, we demonstrated another easily calcul-
able and amenable statistical methodology for the gen-
eration of virtual kinase-focused libraries.
This methodology is based on the observation that
various physicochemical properties of known kinase
active compounds such as molecular weight, polar sur-
face area, and rotatable bonds are unique for this struc-
tural target class and can be used to differentiate kinase
active compounds from molecules of other structural
classes. This method calculates a kinase-likeness score
based on property distribution ranges of nine physico-
chemical descriptors derived from known kinase active
compounds. These physicochemical properties are mole-
cular weight, SlogP, TPSA, rotatable bonds, hydrogen
bond acceptors and donors, number of rings, number of
nitrogen and oxygen atoms. Previous studies of making
kinase-focused libraries use scaffold-based and similar-
ity-based filters, which are primarily inclusive filters.
These methodologies obtain enrichment by including
molecules containing scaffolds identified in known
actives. Such methods are popular, but the collected
compounds lack structural diversity, since they are all
based on either the same or similar known scaffolds. By
comparison, our physicochemical filtering scheme
achieves enrichment by including molecules that exhibit
certain desirable physicochemical properties. Since this
method relies solely on the physicochemical properties,
any selection done using it becomes independent of
known scaffolds. Hence the possibility of finding novel
scaffolds that are structurally unrelated to known kinase
actives is greatly increased. Using an example of kinase
drug Sunitinib, we showed that focused libraries based
on physicochemical property screening are more diverse
than those generated by structure based techniques.
Our method can be used to prioritize small molecule
databases for kinase-based virtual screening. Subsequent
to database prioritization, the method can be used to
constrain the size of screening databases and create
focused libraries. The method can even be used to guide
the de novo design of molecules prior to synthesis and
testing. Extension of this method to improve the quality
of other focused libraries is easily possible; the scoring
function is readily modifiable since new physicochemical
parameters may be added and less useful ones may be
deleted.
Using our kinase-likeness score and a validated cor-
relation matrix-based score for comparison, we showed
that the MLSMR database compounds are much closer
to kinase actives, in terms of physicochemical proper-
ties, than compounds in the NCI and NPD databases.
We also developed and tested a kinase-focused library
based on our kinase-likeness score and showed its
superior enrichment for three specific kinase targets
from different branches of the human kinome, relative
to random screening of a collection of compounds. In
each case, the focused library showed three to four
times more enrichment compared to random screening
of compounds. Given the demonstrated performance
of our kinase-like scoring function for generating
enriched libraries, we suggest that it may be useful as
a first step in kinase-targeted virtual screening
workflows.
Additional material
Additional file 1: Distribution maps of physicochemical descriptors.
Statistical parameters based on the distribution maps of nine calculated
physicochemical descriptors for five databases (DB): WDI, NPD, NCI,
MLSMR, and KBD. Also included is the number of compounds (Total),
outliers, average (Avg), standard deviation (SD), and P10-P90 (range
covering 80% of the compounds) values.
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Page 10 of 12Additional file 2: Correlation matrix of physicochemical descriptors.
Correlation matrix between nine physicochemical descriptors for the
WDI, NPD, NCI, and MLSMR databases.
Additional file 3: Distribution map of Kinase-likeness score (KLS).
Distribution of KLS for the WDI, NPD, NCI, and MLSMR databases.
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